Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e98–e100. doi: 10.1097/QAI.0b013e31827a34b2

Table 1.

Univariate analysis of factors associated with the presence of RPV RAMs

Factors OR 95%CI p-value* Global p-value**
Age, years 0.767
 18–30 1
 31–40 0.76 0.37 to 1.56 0.457
 41–50 0.99 0.46 to 2.14 0.985
 >50 0.72 0.23 to 2.21 0.564

Sex 0.821
 Male 1
 Female 1.07 0.58 to 1.97 0.821

Exposure 0.177
 Heterosexual contact 1
 Homosexual contact 0.93 0.44 to 1.98 0.847
 Other/Unknown 1.98 0.92 to 4.25 0.079

Country income level 0.027
 Upper middle + High 1
 Lower middle 2.41 1.10 to 5.26 0.027

Previous AIDS 0.721
 No 1
 Yes 0.89 0.49 to 1.65 0.721

CD4, cells/μl 0.156
 ≤50 1
 51–100 0.65 0.26 to 1.65 0.369
 101–200 0.6 0.27 to 1.34 0.217
 >200 0.61 0.28 to 1.31 0.203

HIV RNA, copies/ml 0.931
 ≤50,000 1
 50,001–250,000 0.98 0.50 to 1.93 0.950
 >250,000 0.97 0.44 to 2.11 0.931

HIV-1 subtype 0.928
 B 1
 Non B 1.04 0.48 to 2.24 0.928
*

Individual p-values are adjusted for missing values.

**

Global p-values for age, CD4 and HIV RNA are tests for trend. Global p-values exclude missing values.